The drug is a novel gene therapy to treat knee OA. Kolon developed it at a cost of more than 200 billion won ($143 million) since 1999. After clinical trials in Korea and the United States, the drug ...
Anchor] Do you remember the so-called 'Invossa incident' that caused a stir in society five years ago?It was released as the ...
Even if Kolon Group Chairman Lee Woong-yeol and others were acquitted in the first trial, the victims of the Invossa incident ...
Brace for the onslaught of Chinese EVs and Trump’s tariff (KOR) ...